It's a distinct possibility. However, I do remember reading anti-dilution clauses in the $5 Million loan agreement, so that might be the one thing that could prevent the company from issuing more shares. But since the company has already breached the terms of the loan agreement, this is quite likely a moot point.
The only other possibility, is that someone will remind the company that given their recent history they are walking a tightrope as far as the SEC is concerned. In my opinion they would be well advised not to play any games, and to govern themselves accordingly.
(2)
(0)
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links